A decoy receptor 3 analogue reduces localised defects in phagocyte function in pneumococcal pneumonia

Thorax

Volumn 67, Issue 11, 2012, Pages 985-992

  Marriott, Helen M ^a   Daigneault, Marc ^a   Thompson, Alfred A R ^a,b   Walmsley, Sarah R ^a,b   Gill, Sharonjit K ^a   Witcher, Derrick R ^c   Wroblewski, Victor J ^c   Hellewell, Paul G ^d   Whyte, Moira K B ^a,b   Dockrell, David H ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECOY 3 RECEPTOR A; DECOY RECEPTOR 3; FAS LIGAND; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE; GLD GENE; IPR GENE; LUNG; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

EID: 84868194633     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201591     Document Type: Article

References (39)

1. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893-902.
2. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999;33:29-55. (Pubitemid 30083118)
3. Liles WC, Kiener PA, Ledbetter JA, et al. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996;184:429-40. (Pubitemid 26324096)
4. Matute-Bello G, Liles WC, Steinberg KP, et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999;163:2217-25. (Pubitemid 29382230)
5. Kemp K, Bruunsgaard H, Skinhoj P, et al. Pneumococcal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells. Infect Immun 2002;70:5019-25.
6. Matute-Bello G, Liles WC, Frevert CW, et al. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen. J Infect Dis 2005;191:596-606. (Pubitemid 40216676)
7. Matute-Bello G, Frevert CW, Liles WC, et al. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect Immun 2001;69:5768-76. (Pubitemid 32786516)
8. Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009;30:180-92.
9. Dockrell DH. Apoptotic cell death in the pathogenesis of infectious diseases. J Infect 2001;42:227-34. (Pubitemid 32700818)
10. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76. (Pubitemid 24106378)
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-17.
12. Kobayashi S, Hirano T, Kakinuma M, et al. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem Biophys Res Commun 1993;191:617-24. (Pubitemid 23222680)
13. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
14. Nijhawan D, Fang M, Traer E, et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003;17:1475-86. (Pubitemid 36734705)
15. Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999;274:13733-6.
16. Migone TS, Zhang J, Luo X, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002;16:479-92. (Pubitemid 34260924)
17. Dockrell DH, Marriott HM, Prince LR, et al. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol 2003;171:5380-8. (Pubitemid 37432824)
18. Walmsley SR, Chilvers ER, Thompson AA, et al. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J Clin Invest 2011;121:1053-63.
19. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
20. Neff TA, Guo RF, Neff SB, et al. Relationship of acute lung inflammatory injury to Fas/FasL system. Am J Pathol 2005;166:685-94. (Pubitemid 40315626)
21. Marks M, Burns T, Abadi M, et al. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun 2007;75:1586-97. (Pubitemid 46559422)
22. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009;119:1899-909.
23. Kadioglu A, Coward W, Colston MJ, et al. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect Immun 2004;72:2689-97. (Pubitemid 38542395)
24. Han B, Wu J. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression. J Immunol 2009;183:8157-66.
25. Hsu TL, Wu YY, Chang YC, et al. Attenuation of Th1 response in decoy receptor 3 transgenic mice. J Immunol 2005;175:5135-45.
26. Wroblewski VJ, Witcher DR, Becker GW, et al. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem Pharmacol 2003;65:657-67. (Pubitemid 36144253)
27. Omokaro SO, Desierto MJ, Eckhaus MA, et al. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model. J Immunol 2009;182:3414-22.
28. Korner H, Cretney E, Wilhelm P, et al. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J Exp Med 2000;191:89-96. (Pubitemid 30043650)
29. LeMessurier K, Hacker H, Tuomanen E, et al. Inhibition of T cells provides protection against early invasive pneumococcal disease. Infect Immun 2010;78:5287-94.
30. Weber SE, Tian H, Pirofski LA. CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J Immunol 2011;186:432-42.
31. Davidson WF, Calkins C, Hugins A, et al. Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells. J Immunol 1991;146:4138-48.
32. Speert DP, Thorson L. Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing. Infect Immun 1991;59:1893-8.
33. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferongamma during recovery from influenza infection. Nat Med 2008;14:558-64. (Pubitemid 351655219)
34. Cohavy O, Zhou J, Granger SW, et al. LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine. J Immunol 2004;173:251-8. (Pubitemid 38797349)
35. Papadakis KA, Zhu D, Prehn JL, et al. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol 2005;174:4985-90.
36. Jungbeck M, Daller B, Federhofer J, et al. Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation. Immunology 2009;128:451-8.
37. Shih DQ, Barrett R, Zhang X, et al. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PloS One 2011;6:e16090.
38. Marriott HM, Jackson LE, Wilkinson TS, et al. Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia. Am J Respir Crit Care Med 2008;177:887-95. (Pubitemid 351600667)
39. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 2008;8:782-98.